1. Home
  2. TIGO vs ASND Comparison

TIGO vs ASND Comparison

Compare TIGO & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Millicom International Cellular S.A.

TIGO

Millicom International Cellular S.A.

HOLD

Current Price

$87.34

Market Cap

14.3B

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$221.07

Market Cap

14.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIGO
ASND
Founded
1990
2006
Country
Luxembourg
Denmark
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
14.5B
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
TIGO
ASND
Price
$87.34
$221.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$68.30
$281.50
AVG Volume (30 Days)
1.5M
548.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.91
$96.35
Revenue Next Year
$4.06
$44.91
P/E Ratio
$10.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.62
$161.09
52 Week High
$89.49
$250.74

Technical Indicators

Market Signals
Indicator
TIGO
ASND
Relative Strength Index (RSI) 59.06 40.61
Support Level $47.16 $215.18
Resistance Level N/A $236.58
Average True Range (ATR) 3.71 7.71
MACD 0.34 -2.89
Stochastic Oscillator 82.20 18.59

Price Performance

Historical Comparison
TIGO
ASND

About TIGO Millicom International Cellular S.A.

Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia, Nicaragua, Panama, El Salvador, Guatemala, Paraguay, Colombia, Ecuador, Uruguay, and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 145 million people, serving nearly 60 million customers. Its fixed-line networks reach 22 million homes, serving about 5.6 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm also formed a joint venture to acquire Telefónica's operations in Chile.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: